Loading…
Reported covered position: Legislative Analyst, NIH OLPA; Health Policy Fellow (unpaid), House Energy & Commerce, Health Subcommittee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R.5269 - RESULTS Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COMMISSION ON LABORATORY ACCREDITATION via RUBRUM ADVISING
2026 · third_quarter · Q3
H.R.5269 - RESULTS Act
Filing targets: HOUSE OF REPRESENTATIVES
COMMISSION ON LABORATORY ACCREDITATION via RUBRUM ADVISING
2026 · third_quarter · RR
Source: Senate LDA
Clinical laboratory payment; CLIA
Clinical laboratory payment; CLIA
HARRISON.AI via RUBRUM ADVISING
2026 · first_quarter · Q1
Citizen petition on a 510(k) exemption pathway for CAD/CADt radiology devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HARRISON.AI via RUBRUM ADVISING
2025 · fourth_quarter · Q4
Citizen petition on a 510(k) exemption pathway for CAD/CADt radiology devices
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HARRISON.AI via RUBRUM ADVISING
2025 · third_quarter · RR
FDA regulation of CAD/CADt devices in radiology
COGNITO THERAPEUTICS via RUBRUM ADVISING
2025 · third_quarter · RR
Coverage for non-invasive medical devices to treat Alzheimer's disease.
Coverage for non-invasive medical devices to treat Alzheimer's disease.
Coverage for non-invasive medical devices to treat Alzheimer's disease.